Tag Archives: Treatment

Healthcare workers in Cape Town ambivalent about patients who disengage from HIV treatment

A qualitative study sought to understand healthcare workers’ perspectives on patients who disengage from antiretroviral therapy (ART) at a clinic in Cape Town, South Africa. Results showed that healthcare workers had contradictory feelings about these patients, ranging from empathy to anger. Having sub-optimal adherence to or stopping HIV treatment can lead to drug resistance, HIV… Read More »

FDA Approves Rylaze for the Treatment of Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

FDA Approves Rylaze for the Treatment of Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma DUBLIN, June 30, 2021 /PRNewswire/ — Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced the U.S. Food and Drug Administration (FDA) approval of Rylaze (asparaginase erwinia chrysanthemi (recombinant)-rywn) for use as a component of a multi-agent chemotherapeutic regimen for the treatment of acute… Read More »

Is There Treatment for Varicose Veins?

What Are Varicose Veins, and What Causes Them? Blood is meant to travel from your heart throughout your body via your veins. These veins have valves that open to let blood flow past and close off behind it. When these valves aren’t working correctly or become weak, blood is then backed up around the vein… Read More »

Chiesi Global Rare Diseases Announces FDA Approval of Ferriprox (deferiprone) for Treatment of Transfusional Iron Overload due to Sickle Cell Disease

May 1, 2021 Approval is based on demonstrated reduction in liver iron concentration Expanded indications for patients with sickle cell disease or other anemias, as well as thalassemia – BOSTON, May 1, 2021 /PRNewswire/ — Chiesi Global Rare Diseases, a business unit of Chiesi Farmaceutici S.p.A., an international research-focused healthcare Group (Chiesi Group), announced today… Read More »

FDA Approves Kimyrsa (oritavancin) for the Treatment of Adult Patients with Acute Bacterial Skin and Skin Structure Infections (ABSSSI)

FDA Approves Kimyrsa (oritavancin) for the Treatment of Adult Patients with Acute Bacterial Skin and Skin Structure Infections (ABSSSI) MORRISTOWN, N.J., March 15, 2021 (GLOBE NEWSWIRE) — Melinta Therapeutics, LLC (Melinta), a commercial-stage company focused on the development and commercialization of novel antibiotics, today announced that the U.S. Food and Drug Administration (FDA) has approved… Read More »

Dolutegravir superior to standard-of-care treatment in children and adolescents

Dolutegravir-based treatment was superior to treatment based on efavirenz or a boosted protease inhibitor in children and adolescents, both as first-line or second-line treatment, a large international study has concluded. Dr Anna Turkova of the United Kingdom Medical Research Council presented the 96-week results of the ODYSSEY study at the 2021 virtual Conference on Retroviruses… Read More »